Intersectoral health interventions to improve the well-being of people living with type 2 diabetes: a scoping review protocol.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
21 May 2024
Historique:
medline: 22 5 2024
pubmed: 22 5 2024
entrez: 21 5 2024
Statut: epublish

Résumé

Intersectoral collaboration is a collaborative approach between the health sectors and other sectors to address the interdependent nature of the social determinants of health associated with chronic diseases such as diabetes. This scoping review aims to identify intersectoral health interventions implemented in primary care and community settings to improve the well-being and health of people living with type 2 diabetes. This protocol is developed by the Arksey and O'Malley (2005) framework for scoping reviews and the Levac This review does not require ethical approval. The results will be disseminated through a peer-reviewed publication and presentations to stakeholders.

Identifiants

pubmed: 38772897
pii: bmjopen-2023-080659
doi: 10.1136/bmjopen-2023-080659
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e080659

Informations de copyright

© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Sopie Marielle Yapi (SM)

Centre de Recherche du Centre Hospitalier de l'Universite de Montreal, Montreal, Quebec, Canada.

Marguerite Boudrias (M)

Centre de Recherche du Centre Hospitalier de l'Universite de Montreal, Montreal, Quebec, Canada.

Alexandre Tremblay (A)

Centre de Recherche du Centre Hospitalier de l'Universite de Montreal, Montreal, Quebec, Canada.

Gabrielle Belanger (G)

Centre de Recherche du Centre Hospitalier de l'Universite de Montreal, Montreal, Quebec, Canada.

Nadia Sourial (N)

Centre de Recherche du Centre Hospitalier de l'Universite de Montreal, Montreal, Quebec, Canada.
Department of Health Management, Evaluation & Policy, Université de Montréal, Montreal, Quebec, Canada.

Antoine Boivin (A)

Centre de Recherche du Centre Hospitalier de l'Universite de Montreal, Montreal, Quebec, Canada.
Department of Family and Emergency Medicine, Faculty of Medicine, Université de Montréal, Montreal, Quebec, Canada.

Maxime Sasseville (M)

Université Laval, Quebec, Quebec, Canada.
VITAM Centre de Recherche en Santé Durable, Quebec, Quebec, Canada.

André Côté (A)

VITAM Centre de Recherche en Santé Durable, Quebec, Quebec, Canada.
Département de management, Université Laval, Quebec, Quebec, Canada.
Centre de recherche en gestion des services de santé, Université Laval, Quebec, Quebec, Canada.

Jean-Baptiste Gartner (JB)

VITAM Centre de Recherche en Santé Durable, Quebec, Quebec, Canada.
Département de management, Université Laval, Quebec, Quebec, Canada.
Centre de recherche en gestion des services de santé, Université Laval, Quebec City, Quebec, Canada.

Nadine Taleb (N)

Institut de recherches cliniques de Montreal, Montreal, Quebec, Canada.
Centre Hospitalier de l'Universite de Montreal, Montreal, Quebec, Canada.
Universite de Montreal, Montreal, Quebec, Canada.

Marie-Eve Lavoie (ME)

Centre de Recherche du Centre Hospitalier de l'Universite de Montreal, Montreal, Quebec, Canada.

Emmanuelle Trépanier (E)

Department of Family and Emergency Medicine, Faculty of Medicine, Université de Montréal, Montreal, Quebec, Canada.

Brigitte Vachon (B)

Universite de Montreal, Montreal, Quebec, Canada.

Marcel Labelle (M)

Centre de Recherche du Centre Hospitalier de l'Universite de Montreal, Montreal, Quebec, Canada.

Géraldine Layani (G)

Centre de Recherche du Centre Hospitalier de l'Universite de Montreal, Montreal, Quebec, Canada geraldine.layani@umontreal.ca.
Department of Family and Emergency Medicine, Faculty of Medicine, Université de Montréal, Montreal, Quebec, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH